In Vivo Imaging of Tumor Physiological, Metabolic, and Redox Changes in Response to the Anti-Angiogenic Agent Sunitinib: Longitudinal Assessment to Identify Transient Vascular Renormalization

EPR Oxygen Images Predict Tumor Control by a 50% Tumor Control Radiation Dose

(2013) M. Elas et al.   CANCER RESEARCH

Absolute oxygen R1eimaging in vivo with pulse electron paramagnetic resonance

(2013) Boris Epel et al.   MAGNETIC RESONANCE IN MEDICINE

Metabolic Imaging of Patients with Prostate Cancer Using Hyperpolarized [1-13C]Pyruvate

(2013) S. J. Nelson et al.   Science Translational Medicine

Hyperpolarized 13C Spectroscopy Detects Early Changes in Tumor Vasculature and Metabolism after VEGF Neutralization

(2012) S. E. Bohndiek et al.   CANCER RESEARCH

The relationship between tissue oxygenation and redox status using magnetic resonance imaging

(2012) FUMINORI HYODO et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

EPR oxygen imaging and hyperpolarized13C MRI of pyruvate metabolism as noninvasive biomarkers of tumor treatment response to a glycolysis inhibitor 3-bromopyruvate

(2012) Shingo Matsumoto et al.   MAGNETIC RESONANCE IN MEDICINE

Longitudinal Imaging Studies of Tumor Microenvironment in Mice Treated with the mTOR Inhibitor Rapamycin

(2012) Keita Saito et al.   PLoS One

Imaging Key Biomarkers of Tumor Angiogenesis

(2012) Marina V. Backer et al.   Theranostics

Antiangiogenic Agent Sunitinib Transiently Increases Tumor Oxygenation and Suppresses Cycling Hypoxia

(2011) S. Matsumoto et al.   CANCER RESEARCH

Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion

(2011) A. G. Sorensen et al.   CANCER RESEARCH

Monitoring Tumor Response to Antiangiogenic Sunitinib Therapy with 18F-Fluciclatide, an 18F-Labeled  V 3-Integrin and  V 5-Integrin Imaging Agent

(2011) M. R. Battle et al.   JOURNAL OF NUCLEAR MEDICINE

Biomarkers of response and resistance to antiangiogenic therapy

(2009) Rakesh K. Jain et al.   Nature Reviews Clinical Oncology

A New Target for Tumor Therapy

(2009) Rakesh K. Jain   NEW ENGLAND JOURNAL OF MEDICINE

Epidermal Growth Factor Receptor Inhibition Modulates the Microenvironment by Vascular Normalization to Improve Chemotherapy and Radiotherapy Efficacy

(2009) George J. Cerniglia et al.   PLoS One

Simultaneous imaging of tumor oxygenation and microvascular permeability using Overhauser enhanced MRI

(2009) S. Matsumoto et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Decrease in Tumor Cell Oxygen Consumption after Treatment with Vandetanib (ZACTIMA™; ZD6474) and its Effect on Response to Radiotherapy

(2009) Réginald Ansiaux et al.   RADIATION RESEARCH

Impact of Angiogenesis Inhibition by Sunitinib on Tumor Distribution of Temozolomide

(2008) Q. Zhou et al.   CLINICAL CANCER RESEARCH

Magnetic Resonance Imaging-Measured Blood Flow Change after Antiangiogenic Therapy with PTK787/ZK 222584 Correlates with Clinical Outcome in Metastatic Renal Cell Carcinoma

(2008) C. de Bazelaire et al.   CLINICAL CANCER RESEARCH

Use of a Novel Arg-Gly-Asp Radioligand, 18F-AH111585, to Determine Changes in Tumor Vascularity After Antitumor Therapy

(2008) M. S. Morrison et al.   JOURNAL OF NUCLEAR MEDICINE